Literature DB >> 22751417

Relationship between serum sex hormones levels and degree of benign prostate hyperplasia in Chinese aging men.

Qin-Song Zeng1, Chuan-Liang Xu, Zhi-Yong Liu, Hui-Qing Wang, Bo Yang, Wei-Dong Xu, Tai-Le Jin, Cheng-Yao Wu, Gang Huang, Zheng Li, Bo Wang, Ying-Hao Sun.   

Abstract

Benign prostatic hyperplasia (BPH) is one of the most common medical conditions in middle aged and older men. This study investigated the relationship between serum levels of sex hormones and measures of BPH in the aging male population of China. Prostate symptoms were assessed as part of a free health screening program for men ≥ 40 years of age. The examination included digital rectal examination, determination of serum prostate-specific antigen levels, International Prostate Symptom Score (IPSS) and transrectal ultrasonography. Serum levels of total testosterone (TT), sex hormone binding globulin (SHBG), free testosterone (FT), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin (PRL) and estradiol (E(2)) were evaluated. The men also completed a health and demographics questionnaire and received a detailed physical examination. The final study population consisted of 949 men with a mean age of 58.9 years. Pearson correlation analysis indicated that there were significant correlations between age and levels of all sex hormones except TT, and between age and prostate volume (PV; r=0.243; P<0.01) or IPSS (r=0.263; P<0.01). Additional significant correlations were found between IPSS and serum levels of LH (r=0.112; P<0.01) and FSH (r=0.074; P<0.05), but there were no significant correlations between sex hormone levels and PV. Multivariate linear regression analysis showed significant correlations between age and body mass index (BMI) with PV (P<0.0001). In addition, there was a significant correlation between age and PV with IPSS (P<0.0001). Serum sex hormone levels did not correlate with PV or IPSS. The effects of endocrine changes on measures of BPH in aging men require further investigation in longitudinal and multicenter studies that include patients with all severities of BPH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751417      PMCID: PMC3734997          DOI: 10.1038/aja.2012.32

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  30 in total

1.  Determination of prostate volume by transrectal ultrasound.

Authors:  M K Terris; T A Stamey
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

2.  Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland.

Authors:  H Wennbo; J Kindblom; O G Isaksson; J Törnell
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

3.  Prolactin and prolactin receptors are expressed and functioning in human prostate.

Authors:  M T Nevalainen; E M Valve; P M Ingleton; M Nurmi; P M Martikainen; P L Harkonen
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  Serum glycoprotein hormones and their free alpha-subunit in a healthy elderly population selected according to the SENIEUR protocol. Analyses with ultrasensitive time resolved fluoroimmunoassays.

Authors:  S Madersbacher; T Stulnig; L A Huber; D Schönitzer; S Dirnhofer; G Wick; P Berger
Journal:  Mech Ageing Dev       Date:  1993-10-15       Impact factor: 5.432

5.  Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia.

Authors:  N N Stone; S J Clejan
Journal:  J Androl       Date:  1991 Nov-Dec

6.  Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study.

Authors:  A Gray; H A Feldman; J B McKinlay; C Longcope
Journal:  J Clin Endocrinol Metab       Date:  1991-11       Impact factor: 5.958

7.  High prevalence of benign prostatic hypertrophy in the community.

Authors:  W M Garraway; G N Collins; R J Lee
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

8.  A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia.

Authors:  P H Gann; C H Hennekens; C Longcope; W Verhoek-Oftedahl; F Grodstein; M J Stampfer
Journal:  Prostate       Date:  1995-01       Impact factor: 4.104

9.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

10.  The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring.

Authors:  B E Henderson; L Bernstein; R K Ross; R H Depue; H L Judd
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

View more
  6 in total

1.  Giant prostatic hyperplasia and its causes.

Authors:  Marius Anglickis; Gediminas Platkevičius; Rokas Stulpinas; Lina Miklyčiūtė; Giedrė Anglickienė; Vytautas Keina; Edmundas Štarolis; Audrius Gradauskas
Journal:  Acta Med Litu       Date:  2019

2.  Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study.

Authors:  Peng Zhang; Wan-Li Hu; Bei Cheng; Yang-Jun Zeng; Xing-Huan Wang; Tong-Zu Liu; Wei-Bing Zhang
Journal:  Int Urol Nephrol       Date:  2015-12-19       Impact factor: 2.370

3.  Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?

Authors:  Aleksandra Rył; Iwona Rotter; Tomasz Miazgowski; Marcin Słojewski; Barbara Dołęgowska; Anna Lubkowska; Maria Laszczyńska
Journal:  Diabetol Metab Syndr       Date:  2015-10-29       Impact factor: 3.320

4.  Minimally invasive simple prostatectomy for a case of giant benign prostatic hyperplasia.

Authors:  Qin-Song Zeng; Yong-Bin Zhao; Bang-Qi Wang; Min Ying; Wei-Lie Hu
Journal:  Asian J Androl       Date:  2017 Nov-Dec       Impact factor: 3.285

5.  Clinical Implication of Enlarged Prostate in Patients with the Ileal Pouch-anal Anastomosis for Inflammatory Bowel Disease.

Authors:  Lei Lian; Emmanuel Obusez; Erick M Remer; Manoj Monga; Bo Shen
Journal:  Gastroenterology Res       Date:  2018-02-23

Review 6.  Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension?

Authors:  Wolfgang Kopp
Journal:  Nutr Metab Insights       Date:  2018-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.